Company Overview
The Kroger Co. functions as a leading food and drug retailer within the United States, operating a diverse portfolio that includes combination food and drug stores, multi-department locations, marketplace stores, and price impact warehouses. These combination food and drug stores specifically offer natural food and organic sections, pharmacies, and general merchandise to serve a broad consumer base. The company is classified within the Consumer Defensive sector and the Grocery Stores industry, a positioning that typically implies lower sensitivity to economic cycles compared to cyclical industries due to the essential nature of grocery products. With a market capitalization of $44.96B and annual revenue reaching $147.64B, the entity demonstrates substantial scale supported by a workforce of 400000 employees. These financial figures indicate that The Kroger Co. operates as a major systemic player in the retail landscape, commanding significant market share and possessing the operational capacity to influence pricing and inventory management on a national level.
Financial Health
The company reports a total revenue of $147.64B over the trailing twelve months, generating a net income of $1.02B and an EBITDA of $7.96B. The substantial disparity between the $147.64B in revenue and the $1.02B in net income reveals a cost structure characterized by thin profit margins typical of the grocery industry, where high operating expenses and low pricing power constrain profitability. Despite the modest net income, the company maintains free cash flow of $3.43B, which provides significant financial flexibility for capital expenditures, debt repayment, or strategic acquisitions without relying on external financing. The gross margin stands at 23.3%, reflecting the pricing dynamics and supply chain efficiency required to cover the cost of goods sold before operating expenses. Operating margins are reported at 3.5%, indicating the efficiency of the company's core business operations before interest and taxes. Profit margins sit at 0.7%, which is the final metric showing the portion of revenue that translates into actual earnings after all expenses, including interest and taxes, have been deducted. Regarding liquidity and leverage, the company holds $3.33B in cash against total debt of $24.68B, resulting in a debt-to-equity ratio of 415.77. This high debt-to-equity figure suggests a leveraged balance sheet where debt obligations significantly outweigh equity capitalization, requiring careful management of cash flow to meet interest payments. The current ratio is 0.80, a metric below 1.0 that indicates the company's current assets are insufficient to cover its current liabilities without relying on external funding or asset sales. Return on Equity is 14.4%, suggesting that the company generates a substantial return on the shareholders' equity invested, while Return on Assets is 5.6%, which reflects the overall efficiency of the company in utilizing its total asset base to generate profits.
Valuation Assessment
The trailing twelve-month P/E ratio is 47.55, whereas the forward P/E ratio is significantly lower at 13.02. This stark difference between the trailing and forward P/E ratios implies that the market is pricing in a substantial expected increase in future earnings, potentially driven by one-time items or a normalization of current performance rather than sustained organic growth. The price-to-book ratio is 5.93, indicating that the market values the company's equity at nearly six times its book value, which suggests a significant market premium over the tangible net assets of the firm. Alternative valuation metrics provide further context, with the price-to-sales ratio at 0.30 and the EV/EBITDA at 9.56; these figures suggest that the company is trading at a relatively low multiple of its sales and enterprise value relative to earnings before interest, taxes, depreciation, and amortization. Regarding trading range, the stock has a 52-week high of $76.58 and a 52-week low of $58.60. To determine the current position relative to this range, one must note that the current price sits below the 52-week high of $76.58 but above the 52-week low of $58.60, placing the valuation within its recent historical band. The beta value is 0.59, which indicates that the stock's price volatility is less than 60% of the broader market's volatility, suggesting it behaves as a defensive asset that is less sensitive to overall market swings.
Growth & Income
Revenue growth is recorded at 1.2% year-over-year, while earnings growth is reported at 50.1% year-over-year. The fact that earnings are growing significantly faster than revenue implies that the company is improving its operational efficiency, leveraging economies of scale, or managing costs effectively to expand profit margins even as top-line sales increase moderately. As a dividend payer, the company offers a dividend yield of 1.9% and maintains a payout ratio of 87.0%. This high payout ratio indicates that the company distributes a large portion of its earnings to shareholders, which may limit the funds available for reinvestment but provides consistent income to investors, provided earnings remain stable. Given the high payout ratio relative to the current earnings growth rate, the sustainability of the dividend depends on the ability to maintain or grow earnings to keep the payout ratio from becoming excessive if earnings growth slows. The overall growth and income profile presents a mixed picture of modest top-line expansion combined with a sharp increase in profitability and a commitment to returning cash to shareholders through a substantial dividend yield.